BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/30/2023 12:54:07 PM | Browse: 353 | Download: 1222
 |
Received |
|
2023-04-24 08:04 |
|
Peer-Review Started |
|
2023-04-24 08:05 |
|
First Decision by Editorial Office Director |
|
2023-05-08 01:58 |
|
Return for Revision |
|
2023-05-08 01:58 |
|
Revised |
|
2023-05-27 14:31 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-06-13 02:58 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-06-13 08:20 |
|
Articles in Press |
|
2023-06-13 08:20 |
|
Edit the Manuscript by Language Editor |
|
2023-06-20 22:05 |
|
Typeset the Manuscript |
|
2023-06-25 04:34 |
|
Publish the Manuscript Online |
|
2023-06-30 12:54 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ying-Jie Li, Dong-Xin Tang, Hong-Ting Yan, Bing Yang, Zhu Yang and Feng-Xi Long |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
|
| Guizhou Provincial Science and Technology Program (Qian Kehe Foundation-ZK[2022] General 498, Qian Kehe Foundation-ZK [2022] General 487, Qian Kehe Support [2021] General 095, Qian Kehe Platform Talent [2020]5013) |
|
| Qian Kehe Foundation-ZK [2022] General 487 |
|
| Qian Kehe Support [2021] General 095 |
|
| National Key R&D Program Project (2019YFC1712504); Guizhou Traditional Chinese Medicine Tumor Inheritance and Science and Technology Innovation Talent Base (No. Deaf leader-[2018] No. 3) |
|
| Guizhou high-level innovative talent training plan (100 levels) (No. Qian Kehe Talents [2016] No. 4032) |
|
| Yang Zhu, Guizhou Province, “Traditional Chinese Medicine Oncology” Graduate Tutor Studio (No. Teaching and research GZS-[2016]08). |
|
|
| Corresponding Author |
Dong-Xin Tang, MD, Digestive Department, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, No.71 Baoshan North Road, Nanming District, Guiyang 550001, Guizhou Province, China. tangdongxin@sina.com |
| Key Words |
Huangqin decoction; Colorectal cancer; Network pharmacology |
| Core Tip |
Huangqin decoction may treat colorectal cancer through multi-component targeting and modulation of multiple signaling pathways. |
| Publish Date |
2023-06-30 12:54 |
| Citation |
Li YJ, Tang DX, Yan HT, Yang B, Yang Z, Long FX. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin Decoction in treating colorectal cancer. World J Clin Cases 2023; 11(19): 4553-4566 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i19/4553.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i19.4553 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
